Mar 24 2020


9:30 am - 4:00 pm

Theralymph Kick off meeting

Due to the restrictive and preventive measures put into place by the European countries, we kicked-off Theralymph on March 24 2020 by videoconference.

 We were honored to introduce our consortium: Dr Kari Alitalo (Finland), Dr Tatiana Petrova (Switzerland), Dr Miikka Vikkula (Belgium), Dr Agnès Noël (Belgium), Dr Lenka Romeislova (Czeck Republic), Dr Gilles Pagès (France), Dr Taija Makinen (Sweden), Flash Therapeutics (France), the Clinical Investigation Center of Toulouse (France) and Inserm Tranfert.

Introduction : Lymphedema is a disorder of the lymphatic vascular system characterized by impaired lymphatic return and swelling of the extremities and accumulation of undrained interstitial fluid/lymph that results in fibrosis and adipose tissue deposition in the affected area. It can be an inherited condition (primary lymphedema) or occurs after cancer surgery and lymph node removal (secondary lymphedema). It causes a significant morbidity and is a common disabling disease affecting more than 120 million people worldwide, however there is no curative treatment for lymphedema. Therefore, our main objective will be to establish a multiple gene therapy for lymphedema. We will focus on women who developed secondary lymphedema after breast cancer. This meeting will consist in presenting the work teams as well as the distribution of each work packages in Theralymph project.

Programme horaire

Theralymph Kick off meeting

09:00 - 09:30
Welcome coffee
10:00 - 10:30
Introduction of the Theralymph project – Barbara Garmy-Susini – France
10:30 - 10:50
Vascular medicine and lymphology Rangueil hospital. Alessandra Bura-Rivière France 2014
10:50 - 11:10
Flash Therapeutics – France (Toulouse)
11:10 - 11:30
Kari Alitalo – Finland (Helsinki)
11:30 - 11:50
Agnès Noël – Belgium (Liège)
11:50 - 12:10
Tatiana Petrova – Switzerland (Lausanne)
12:10 - 13:30
Lunch time
13:30 - 13:50
Miikka Vikkula – Belgium (Leuven)
13:50 - 14:10
Lenka Romeislova – Czeck Republic (Prague)
14:10 - 14:30
Taija Makinen – Sweden (Uppsala)
14:30 - 14:50
Gilles Pagès – France (Nice/Monaco)
14:50 - 15:10
Christiane Dasher-Nadel - Inserm Transfert – France (Marseille)
15:10 - 16:00
General discussion with partner and Ethical advisory board: Pr Bettina Couderc (Toulouse, France), Dr Nicolas Ferry (Paris, France), Dr Stéphane Vignes (Paris, France).
16:00 -
End of the meeting